Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence

OBJECTIVES: To assess the relationship between UK-based patient organisation funding and companies’ commercial interests in rare and non-rare diseases in 2020. DESIGN: Retrospective analysis of the value and volume of payments from pharmaceutical companies to patient organisations in the UK matched...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentilini, Arianna, Parvanova, Iva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410975/
https://www.ncbi.nlm.nih.gov/pubmed/37369404
http://dx.doi.org/10.1136/bmjopen-2022-071138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410975/
https://www.ncbi.nlm.nih.gov/pubmed/37369404
http://dx.doi.org/10.1136/bmjopen-2022-071138

Ejemplares similares